missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18323873

CDC37 Antibody, DyLight 550, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Bio-Techne NBP2-98986R

Product Code. 18323873

  • 4015.00 SEK / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

CDC37 Polyclonal specifically detects CDC37 in Human samples. It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.
Specifications

Specifications

CDC37
Polyclonal
Immunohistochemistry, Immunohistochemistry-Paraffin
CDC37 (cell division cycle 37, S. cerevisiae, homolog), CDC37 cell division cycle 37 homolog, CDC37 cell division cycle 37 homolog (S. cerevisiae), CDC37A, cell division cycle 37 homolog (S. cerevisiae), Hsp90 chaperone protein kinase-targeting subunit, hsp90 co-chaperone Cdc37, P50CDC37
Produced in rabbits immunized with a synthetic peptide corresponding to the N-terminus of human CDC37.
0.1 mL
Cell Cycle and Replication, Membrane Trafficking and Chaperones, Phospho Specific
11140
Store at 4°C in the dark.
IgG
Immunohistochemistry, Immunohistochemistry (Paraffin)
DyLight 550
50mM Sodium Borate
Rabbit
Antigen Affinity-purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.